Paradisus Medical Research

Executive Summary

Paradisus Medical Research is a private clinical research organization (CRO) headquartered in Miami, Florida, founded in 2015. The company specializes in conducting clinical trials across neuroscience and immunology, two high-growth therapeutic areas with significant unmet medical needs. As a commercial-stage CRO, Paradisus partners with biopharmaceutical sponsors to manage trial logistics, patient recruitment, and data collection. While the company lacks publicly disclosed funding, valuation, or pipeline details, its established presence in the competitive Florida CRO market suggests operational stability. The CRO sector benefits from increasing R&D outsourcing by pharma companies, and Paradisus's focus on complex therapeutic areas positions it to capture niche opportunities. However, the absence of visible revenue, partnership announcements, or clinical milestones limits near-term visibility. The company's growth trajectory depends on its ability to secure repeat contracts and expand its therapeutic footprint, especially given the fragmented nature of the CRO industry.

Upcoming Catalysts (preview)

• Q3 2026Announcement of Major Trial Contract in Neuroscience30% success
• Q4 2026Partnership with a Top-20 Pharma for Immunotherapy Trial25% success
• Q2 2026Expansion into New Clinic Sites to Boost Patient Enrollment Capacity50% success